Avecia's remaining business acquired by Nitto Denko
This article was originally published in Scrip
Executive Summary
Growth prospects in the area of nucleic acid medicines have proven too attractive to resist for Nitto Denko, which has acquired the private US firm Avecia Biotechnology.